Upadacitinib as a Therapeutic Option for Scleredema Diabeticorum: A Case Report
International Journal of Dermatology · 10.06.2026
DOI: 10.1111/ijd.70536 ↗Kurz gefasst
Leserbrief in der Zeitschrift International Journal of Dermatology, online erschienen am 10.06.2026. Verfasst von Hsin-Yi Huang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan. Die Arbeit nennt 5 Literaturangaben. Gefördert von: Longyan City Science and Technology Plan Project.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
- Department of Hematology and Rheumatology, Longyan Second Hospital, Longyan, China.
Förderung
- Longyan City Science and Technology Plan Project
Zitieren
APA
Huang, H. Y., Wu, Y., Zeng, X., & Li, M. (2026). Upadacitinib as a Therapeutic Option for Scleredema Diabeticorum: A Case Report. International Journal of Dermatology. https://doi.org/10.1111/ijd.70536
Vancouver
Huang HY, Wu Y, Zeng X, Li M. Upadacitinib as a Therapeutic Option for Scleredema Diabeticorum: A Case Report. International Journal of Dermatology. 2026. doi:10.1111/ijd.70536
BibTeX
@article{Huang2026,
author = {Huang, Hsin-Yi and Wu, Yonglan and Zeng, Xianlin and Li, Man},
title = {Upadacitinib as a Therapeutic Option for Scleredema Diabeticorum: A Case Report},
journal = {International Journal of Dermatology},
year = {2026},
doi = {10.1111/ijd.70536}
}
EUVIMED